Global Small Molecule Drug Discovery Market to Reach $106.91 Billion by 2029, Growing at 12% CAGR

Which drivers are expected to have the greatest impact on the over the small molecule drug discovery market's growth?
The escalating prevalence of chronic illnesses is anticipated to fuel expansion in the small molecule drug discovery market. Chronic illnesses are defined as conditions that endure for over a year, interfere with daily tasks, necessitate ongoing medical attention, or both. Chronic conditions like HIV, cancer, infections, heart disease, and renal disease can be managed using small-molecule drugs, and these drugs tend to be financially accessible for patients with long-term illnesses. As a result, the escalating prevalence of chronic illness is anticipated to fuel the small molecule drug discovery market's growth. For example, a study by the National Institutes of Health (NIH), a biomedical research organization, projected that the number of individuals aged 50 and above in the United States with at least one chronic illness would increase by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Similarly, the population with multimorbidity is projected to surge by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the escalating prevalence of chronic illnesses is driving the expansion of the small molecule drug discovery market.

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

What is the future CAGR of the small molecule drug discovery market, and how will it impact industry expansion?
In recent years, the market size for small molecule drug discovery has seen a robust growth. The market, estimated to be worth $62.44 billion in 2024, is projected to increase to $68.57 billion in 2025, representing a compound annual growth rate (CAGR) of 9.8%. The expansion in the historical period is linked to initiatives for drug repurposing, the automation of drug discovery, boosts in r&d investment, regulatory endorsement for drug development, and the advancements in high-throughput screening.

In the forthcoming years, the market size for small molecule drug discovery is predicted to experience a swift expansion. The growth will reach a staggering $106.91 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. Various factors contributing to this growth during the projected period include the appearance of innovative therapeutic targets, patient-centered drug discovery, the advent of drug-device combination products, the use of actual world evidence, integration of pharmacogenomics, and overall global health issues. Key trends during this period involve fragment-based drug discovery, the implementation of artificial intelligence in drug discovery, RNA-targeted treatments, collaborations and alliances, innovations in drug delivery, and the use of organoids and 3D cell culture models.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What are the most significant trends transforming the small molecule drug discovery market today?
Technological advancements are becoming a prominent trend within the small molecule drug discovery industry. Numerous prominent firms within this market are prioritizing the development of new products. For instance, Dotmatics, an American company specializing in digital science platforms, introduced its Small Molecule Drug Discovery Solution in January 2023. This unique solution is designed with a unified scientific R&D platform, complete with pre-planned workflows and increased data management abilities. It not only minimizes operational weaknesses, but also accelerates the process of converting data insights into decisions.

Which key market segments comprise the small molecule drug discovery market and drive its revenue growth?
The small molecule drug discovery market covered in this report is segmented -

1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:
1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs
2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9834

What regions are at the forefront of small molecule drug discovery market expansion?
North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the small molecule drug discovery market?
Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Is Covered In The Small Molecule Drug Discovery Global Market Report?

• Market Size Forecast: Examine the small molecule drug discovery market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the small molecule drug discovery market for a structured understanding.
• Key Players Overview: Analyze major players in the small molecule drug discovery market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the small molecule drug discovery market.
• Segment Contributions: Evaluate how different segments drive overall growth in the small molecule drug discovery market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the small molecule drug discovery market.
• Industry Challenges: Identify potential risks and obstacles affecting the small molecule drug discovery market.
• Competitive Landscape: Review strategic developments in the small molecule drug discovery market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.